Back to the main directory
EarningsReview / Equity
- Potential Secondaries M&A? by BNP Paribas
- BHP, S32, LITHIUM, EU ETS, US CONTRACTS, STLD, CLF, SSAB, MT by BNP Paribas
- Selected upwards price pressures from Nexperia supply chain disruption by BNP Paribas
- Solid message on the conference call by BNP Paribas
- Corporate contact: feedback by BNP Paribas
- CCBA deal & Q325 sales call: all about growth by BNP Paribas
- Downgrading on valuation, shares are reasonably priced by BNP Paribas
- Giving Away the Golden Goose; Downgrade to Underperform by BNP Paribas
- More Multiple than Megawatt Momentum; Downgrade to Underperform by BNP Paribas
- Q3 25: earnings momentum turning by BNP Paribas
- Haid Group (002311 CH) by HSBC
- OVH slides after FY25: is there a read across for IONOS? by BNP Paribas
- Wallenstam - Growing NAV with high-quality, low-yielding assets by Danske Bank Equity Research
- SMR, FLNC, AMRC Downgrades, Fed Permit Solar Cancellation, Doosan Risk, NXT & GEV 3Q Print + Investor Day by BNP Paribas
- Racing Force - STRONG TOP-LINE PERFORMANCE ACROSS ALL REGIONS by Equita Sim
- Hologic agrees to PE take-private for up to $79/share by BNP Paribas
- Preliminary Q3 results and impressive new CEO by BNP Paribas
- Non material data changes by BNP Paribas
- New CDMO agreement with Roche by BNP Paribas
- Organic growth accelerates with impressive margins by BNP Paribas
- Indutrade - Pieces falling into place for 2026 by Danske Bank Equity Research
- Q3'25 postview: the hopper will take time to refill by BNP Paribas
- Solid Q3 sales, guidance narrowed down, encouraging audits’ conclusions, and a small divestment by BNP Paribas
- Q1 revenues slightly below expectations but FY outlook confirmed by BNP Paribas
- Q3 pre-release: keeping the momentum by BNP Paribas